| Income Statement | 2026-02-28 | 2025-08-31 | 2025-05-31 | 2025-02-28 |
|---|---|---|---|---|
| Revenue | 0 | 0 | -5,438.25* | NaN |
| Cost of goods sold | 62,108 | 0 | 1,812.75* | NaN |
| Gross profit | -62,108 | 0 | -7,251 | NaN |
| Advertising and promotion | 0 | 2,996 | NaN | NaN |
| Depreciation | NaN | 0 | NaN | NaN |
| Due and subscriptions | NaN | 568 | NaN | NaN |
| Interest expense | NaN | 0 | NaN | NaN |
| Dues and subscriptions | 0 | NaN | NaN | NaN |
| Office supplies | 1,317 | 0 | NaN | NaN |
| Delivery | 64 | NaN | NaN | NaN |
| Transfer agent | 1,490 | NaN | NaN | NaN |
| Otc markets fees | 0 | 7,500 | NaN | NaN |
| Professional fees | 10,600 | 20,750 | NaN | NaN |
| Impairment expenses | NaN | NaN | 3,463 | NaN |
| Research and development | 161,426 | NaN | NaN | NaN |
| General and administrative expenses | 0 | NaN | -10,519 | 23,827 |
| Total operating expenses | 174,897 | 31,814 | -7,056 | 23,827 |
| Net income (loss) from operations | -237,005 | -31,814 | NaN | NaN |
| Other income | 0 | NaN | NaN | NaN |
| Interest income | NaN | 0 | NaN | NaN |
| Gain on acquisition | 217,922 | NaN | NaN | NaN |
| Total other income (expense) | 217,922 | 0 | -86,512 | 85,710 |
| Income (gain) before provision for income taxes | -19,083 | -31,814 | -86,707 | 61,883 |
| Provision for income taxes | 0 | 0 | 0 | NaN |
| Net income (gain) | -19,083 | -31,814 | -86,707 | NaN |
| Basic EPS | 0 | 0 | -0.011 | NaN |
| Diluted EPS | 0 | 0 | -0.011 | NaN |
| Basic Average Shares | 16,764,767 | 7,777,000 | 7,777,000 | NaN |
| Diluted Average Shares | 16,764,767 | 7,777,000 | 7,777,000 | NaN |
Exousia Bio, Inc. (LMMY)
Exousia Bio, Inc. (LMMY)